Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 1 or Type 2 diabetes mellitus~* Age\>= 18 years~* Study wound is a Wagner Grade 1 partial thickness or Grade 2 full thickness lesion but without exposed tendon, joint, or bones~* Study wound located on the foot or lower leg~* Study wound must have been present for at least 4 weeks prior to Day 0 but not longer than 2 years~* Adequate circulation to the foot, evidenced by a palpable pulse on the study foot~* Study wound \> 1.0cm2 but \< 20.0cm2~* Written informed consent~Exclusion Criteria:~* Pregnancy, lactation or absence of adequate contraception for fertile women~* Ankle/Brachial Index \< 0.7~* Severe malnutrition~* Clinical evidence of gangrene on any part of the foot with the study wound~* Active or extensive cellulitis extending more than 1 cm beyond wound margin and/or presence of cellulitis with purulent discharge on day 0~* One or more medical condition(s) that in the opinion of the investigator would make the patient an inappropriate candidate for the study~* Active osteomyelitis of the foot with the study wound~* Necrotic toes on the foot with the study wound~* Surgical procedure (other than debridement) on the foot with the study wound the last 21 days prior to screening~* Study wound over a Charcot's joint~* Evidence of deep tissue infection of the study wound at day 0~* Non-study wound on the study foot that is located within 5.0cm from the study wound at day 0~* Random blood sugar reading \> 450 mg/dL~* Alcohol or drug abuse~* Participation in other clinical studies in the last 4 weeks

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).